F. Chabot

7.5k total citations · 2 hit papers
119 papers, 4.0k citations indexed

About

F. Chabot is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, F. Chabot has authored 119 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 22 papers in Cardiology and Cardiovascular Medicine and 19 papers in Surgery. Recurrent topics in F. Chabot's work include Pulmonary Hypertension Research and Treatments (36 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers) and Respiratory Support and Mechanisms (20 papers). F. Chabot is often cited by papers focused on Pulmonary Hypertension Research and Treatments (36 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers) and Respiratory Support and Mechanisms (20 papers). F. Chabot collaborates with scholars based in France, United States and United Kingdom. F. Chabot's co-authors include Ari Chaouat, Olivier Sitbon, Michel Vert, Marc Humbert, Virginie Gressin, Gilbert Habib, E Weitzenblum, Azzedine Yaïci, Gérald Simonneau and Martine Reynaud‐Gaubert and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Virology and Journal of Applied Physiology.

In The Last Decade

F. Chabot

112 papers receiving 3.9k citations

Hit Papers

Pulmonary Arterial Hypertension in France 2006 2026 2012 2019 2006 2010 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Chabot France 26 2.7k 1.3k 500 423 399 119 4.0k
Robert A.S. Ariëns United Kingdom 50 4.1k 1.5× 1.2k 0.9× 529 1.1× 857 2.0× 518 1.3× 160 7.6k
Klaus‐Michael Müller Germany 32 1.8k 0.7× 691 0.5× 128 0.3× 899 2.1× 576 1.4× 147 3.8k
Tetsuro Miyata Japan 32 1.7k 0.6× 642 0.5× 146 0.3× 1.7k 4.0× 494 1.2× 201 3.5k
Darren H. Freed Canada 35 620 0.2× 1.4k 1.0× 306 0.6× 2.0k 4.6× 826 2.1× 229 4.3k
Giovanni Ferrari United States 38 1.5k 0.6× 1.6k 1.2× 88 0.2× 1.3k 3.1× 779 2.0× 170 4.7k
Hendrik Jan Ankersmit Austria 41 686 0.3× 754 0.6× 412 0.8× 2.2k 5.1× 1.3k 3.2× 235 5.8k
Minoru Ōno Japan 37 996 0.4× 1.4k 1.0× 185 0.4× 2.9k 7.0× 964 2.4× 476 6.1k
Kjell S. Sakaríassen Norway 38 1.2k 0.4× 1.8k 1.3× 335 0.7× 1.3k 3.0× 646 1.6× 112 5.0k
Marialuisa Valente Italy 39 1.1k 0.4× 3.1k 2.3× 150 0.3× 2.0k 4.7× 1.3k 3.4× 254 7.1k
Vincent T. Turitto United States 36 1.7k 0.6× 1.2k 0.9× 290 0.6× 973 2.3× 280 0.7× 69 4.6k

Countries citing papers authored by F. Chabot

Since Specialization
Citations

This map shows the geographic impact of F. Chabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Chabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Chabot more than expected).

Fields of papers citing papers by F. Chabot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Chabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Chabot. The network helps show where F. Chabot may publish in the future.

Co-authorship network of co-authors of F. Chabot

This figure shows the co-authorship network connecting the top 25 collaborators of F. Chabot. A scholar is included among the top collaborators of F. Chabot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Chabot. F. Chabot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valentin, Simon, Mathias Poussel, Céline Robert, et al.. (2021). Progression to a severe form of COVID-19 among patients with chronic respiratory diseases. Respiratory Medicine and Research. 81. 100880–100880. 3 indexed citations
2.
Valentin, Simon, Olivier Sitbon, Antoine Beurnier, et al.. (2021). Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs. European Respiratory Journal. 58(5). 2004066–2004066. 11 indexed citations
3.
Decker, Paul A., Vincent Sobanski, T. Moulinet, et al.. (2021). Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up. European Journal of Internal Medicine. 97. 62–68. 7 indexed citations
4.
Zysman, M., Anne Guillaumot, Pierre‐Régis Burgel, et al.. (2019). Prevalence and management of chronic breathlessness in COPD in a tertiary care center. BMC Pulmonary Medicine. 19(1). 95–95. 27 indexed citations
5.
Chabot, F., et al.. (2019). La bronchopneumopathie chronique obstructive. Bulletin de l Académie Nationale de Médecine. 203(1-2). 63–71. 1 indexed citations
6.
Chaouat, Ari, Aboubaker Cherifi, Olivier Sitbon, et al.. (2018). Évaluation de l’IRM cardiaque dans le suivi des patients ayant une hypertension artérielle pulmonaire (EVITA). IRM cardiaque dans le suivi de l’hypertension artérielle pulmonaire. Revue des Maladies Respiratoires. 35(7). 749–758. 2 indexed citations
7.
Poussel, Mathias, et al.. (2017). Occupational Asthma to Detergent Protease Associated With a Late-Phase Neutrophilic Cutaneous Response. Journal of Investigational Allergology and Clinical Immunology. 27(1). 60–62. 1 indexed citations
8.
Huet, D., et al.. (2016). Infection pulmonaire à Mycobacterium malmoense . Difficultés diagnostiques et de thérapeutiques. Revue des Maladies Respiratoires. 34(3). 257–261. 1 indexed citations
9.
Poussel, Mathias, P. Kaminsky, E. Gomez, et al.. (2015). Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: Evidence for a dysregulation at central level. Neuromuscular Disorders. 25(5). 403–408. 38 indexed citations
10.
Zysman, M., Philippe Caramelle, Sabine Le Gouvello, et al.. (2015). Lack of Transcription Factor p53 Exacerbates Elastase-Induced Emphysema in Mice. American Journal of Respiratory Cell and Molecular Biology. 54(2). 188–199. 4 indexed citations
11.
Poussel, Mathias, et al.. (2015). Occupational asthma to “the miracle tree” (Moringa oleifera): first description. The Journal of Allergy and Clinical Immunology In Practice. 3(5). 813–814. 14 indexed citations
12.
Chabot, F., M. Zysman, Julie Perrin, et al.. (2014). Impact de la BPCO : du handicap aux exacerbations. La Presse Médicale. 43(12). 1353–1358. 1 indexed citations
13.
Chaouat, Ari, Olivier Sitbon, Steeve Provencher, et al.. (2014). Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension. European Respiratory Journal. 44(3). 704–713. 52 indexed citations
14.
Cracowski, Jean‐Luc, Bruno Degano, F. Chabot, et al.. (2012). Independent Association of Urinary F2-Isoprostanes With Survival in Pulmonary Arterial Hypertension. CHEST Journal. 142(4). 869–876. 37 indexed citations
15.
Wahl, Denis, Ari Chaouat, Jean‐Pierre Max, et al.. (2010). Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension. Thrombosis Research. 126(6). e418–e422. 31 indexed citations
16.
Chabot, F., Roman Jankowski, Lívia Azeredo Alves Antunes, et al.. (2008). Le syndrome sinobronchique. Revue des Maladies Respiratoires. 18(2). 193–196.
17.
Bakouboula, Babé, Olivier Morel, A. Faure, et al.. (2007). Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 177(5). 536–543. 144 indexed citations
18.
Chabot, F., et al.. (2006). Hypertension portopulmonaire. Revue des Maladies Respiratoires. 23(6). 629–641. 8 indexed citations
19.
Lartaud, Isabelle, et al.. (2006). Metalloproteinase‐9 in circulating monocytes in pulmonary hypertension. Fundamental and Clinical Pharmacology. 20(4). 405–410. 8 indexed citations
20.
Lesur, Olivier, et al.. (1994). Interleukin-6, Interferon-Gamma, and Phospholipid Levels in the Alveolar Lining Fluid of Human Lungs. CHEST Journal. 106(2). 407–413. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026